[
  {
    "ts": "2025-11-14T11:59:00+00:00",
    "headline": "Update on Phase 3 Librexia ACS Trial",
    "summary": "PRINCETON, N.J., November 14, 2025--Update on Phase 3 Librexia ACS Trial",
    "url": "https://finance.yahoo.com/news/phase-3-librexia-acs-trial-115900952.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8dc584cb-7d41-392e-b078-cb04ea3ac2e5",
      "content": {
        "id": "8dc584cb-7d41-392e-b078-cb04ea3ac2e5",
        "contentType": "STORY",
        "title": "Update on Phase 3 Librexia ACS Trial",
        "description": "",
        "summary": "PRINCETON, N.J., November 14, 2025--Update on Phase 3 Librexia ACS Trial",
        "pubDate": "2025-11-14T11:59:00Z",
        "displayTime": "2025-11-14T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a22c0f4ba2f45db46b71129d6d139cfa",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5zreZ1Kd9Toi6AKXoXS8w--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a22c0f4ba2f45db46b71129d6d139cfa.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yg_UQTCl1wCx8KwTt45TEw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a22c0f4ba2f45db46b71129d6d139cfa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/phase-3-librexia-acs-trial-115900952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/phase-3-librexia-acs-trial-115900952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T14:19:50+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Premarket Friday",
    "summary": "Health care stocks were declining premarket Friday, with the Health Care Select Sector SPDR Fund (XL",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-141950471.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "43947110-0ea0-359b-a4fd-7c572595b7d4",
      "content": {
        "id": "43947110-0ea0-359b-a4fd-7c572595b7d4",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Premarket Friday",
        "description": "",
        "summary": "Health care stocks were declining premarket Friday, with the Health Care Select Sector SPDR Fund (XL",
        "pubDate": "2025-11-14T14:19:50Z",
        "displayTime": "2025-11-14T14:19:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-141950471.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-141950471.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "IONS"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T12:59:00+00:00",
    "headline": "Pharma ETFs in Spotlight Following Robust Q3 Earnings Results",
    "summary": "Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.",
    "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "10fc0cfd-b499-32b5-907f-5817647b3297",
      "content": {
        "id": "10fc0cfd-b499-32b5-907f-5817647b3297",
        "contentType": "STORY",
        "title": "Pharma ETFs in Spotlight Following Robust Q3 Earnings Results",
        "description": "",
        "summary": "Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.",
        "pubDate": "2025-11-14T12:59:00Z",
        "displayTime": "2025-11-14T12:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F9Duz3IXY6vI3GQX0iFRbg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jvXjFQvI33DlpnQwQb.s8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PJP"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "XPH"
            },
            {
              "symbol": "FTXH"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "IHE"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T14:42:32+00:00",
    "headline": "Market Chatter: Judge to Decide on Texas AG's Bid to Block Kenvue's Dividend",
    "summary": "A Texas judge will weigh Texas Attorney General Ken Paxton's bid to block Kenvue's (KVUE) November d",
    "url": "https://finance.yahoo.com/news/market-chatter-judge-decide-texas-144232369.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "63b8c9cb-5d45-3bf3-a7ca-af6d097926a7",
      "content": {
        "id": "63b8c9cb-5d45-3bf3-a7ca-af6d097926a7",
        "contentType": "STORY",
        "title": "Market Chatter: Judge to Decide on Texas AG's Bid to Block Kenvue's Dividend",
        "description": "",
        "summary": "A Texas judge will weigh Texas Attorney General Ken Paxton's bid to block Kenvue's (KVUE) November d",
        "pubDate": "2025-11-14T14:42:32Z",
        "displayTime": "2025-11-14T14:42:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-judge-decide-texas-144232369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-judge-decide-texas-144232369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T14:38:04+00:00",
    "headline": "Bristol Myers Slumps After Its Heart Condition Study Gets The Boot",
    "summary": "Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary syndrome.",
    "url": "https://www.investors.com/news/technology/bristol-myers-squibb-acute-coronary-syndrome-study/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e708dcf9-265a-3d3b-9420-000f38c85fae",
      "content": {
        "id": "e708dcf9-265a-3d3b-9420-000f38c85fae",
        "contentType": "STORY",
        "title": "Bristol Myers Slumps After Its Heart Condition Study Gets The Boot",
        "description": "",
        "summary": "Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary syndrome.",
        "pubDate": "2025-11-14T14:38:04Z",
        "displayTime": "2025-11-14T14:38:04Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e708dcf9-265a-3d3b-9420-000f38c85fae/bristol-myers-slumps-after.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722",
          "originalWidth": 1065,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j3JTvymRHXIlwun6knekJg--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722.cf.webp",
              "width": 1065,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w6QlyKN7KTGdJM6jEvgiQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/bristol-myers-squibb-acute-coronary-syndrome-study/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T16:13:08+00:00",
    "headline": "Jim Cramer on Amgen: “Why Not Go Buy That?”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer mentioned in his latest comments. Cramer highlighted the company’s breakthrough medicine, as he remarked: “We had Amgen on the show the other day, announcing a breakthrough in Repatha, its every other week injection squelches cholesterol to a level where it helps prevent heart attacks. Why […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-amgen-why-not-161308203.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e3a44717-3cd9-3dde-a860-4227258a92fe",
      "content": {
        "id": "e3a44717-3cd9-3dde-a860-4227258a92fe",
        "contentType": "STORY",
        "title": "Jim Cramer on Amgen: “Why Not Go Buy That?”",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer mentioned in his latest comments. Cramer highlighted the company’s breakthrough medicine, as he remarked: “We had Amgen on the show the other day, announcing a breakthrough in Repatha, its every other week injection squelches cholesterol to a level where it helps prevent heart attacks. Why […]",
        "pubDate": "2025-11-14T16:13:08Z",
        "displayTime": "2025-11-14T16:13:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RcFryqOLWXyjpn.bSexpBA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/11C66UWKw4HJJjHboXfTPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-why-not-161308203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-why-not-161308203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T16:45:13+00:00",
    "headline": "Bristol Myers Slouches 4% After Experts Say Its Heart Drug Will Fail",
    "summary": "Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary syndrome.",
    "url": "https://www.investors.com/news/technology/bristol-myers-squibb-acute-coronary-syndrome-study/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e708dcf9-265a-3d3b-9420-000f38c85fae",
      "content": {
        "id": "e708dcf9-265a-3d3b-9420-000f38c85fae",
        "contentType": "STORY",
        "title": "Bristol Myers Slouches 4% After Experts Say Its Heart Drug Will Fail",
        "description": "",
        "summary": "Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary syndrome.",
        "pubDate": "2025-11-14T16:45:13Z",
        "displayTime": "2025-11-14T16:45:13Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e708dcf9-265a-3d3b-9420-000f38c85fae/bristol-myers-slouches-4-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722",
          "originalWidth": 1065,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j3JTvymRHXIlwun6knekJg--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722.cf.webp",
              "width": 1065,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w6QlyKN7KTGdJM6jEvgiQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/bristol-myers-squibb-acute-coronary-syndrome-study/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T18:08:48+00:00",
    "headline": "How Recent Moves Are Rewriting the Story for Pfizer",
    "summary": "Pfizer's fair value estimate has inched upward recently, rising from $28.86 to $29.08 per share. The discount rate has climbed slightly as well. Analysts note this shift reflects a blend of enthusiasm for new pipeline additions alongside prudent awareness of industry headwinds. Stay tuned to discover how evolving market developments continue to shape Pfizer's investment outlook and what to watch going forward. Analyst Price Targets don't always capture the full story. Head over to our Company...",
    "url": "https://finance.yahoo.com/news/recent-moves-rewriting-story-pfizer-180848879.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "543fb5e0-b2e5-3b15-8c86-cb747435c666",
      "content": {
        "id": "543fb5e0-b2e5-3b15-8c86-cb747435c666",
        "contentType": "STORY",
        "title": "How Recent Moves Are Rewriting the Story for Pfizer",
        "description": "",
        "summary": "Pfizer's fair value estimate has inched upward recently, rising from $28.86 to $29.08 per share. The discount rate has climbed slightly as well. Analysts note this shift reflects a blend of enthusiasm for new pipeline additions alongside prudent awareness of industry headwinds. Stay tuned to discover how evolving market developments continue to shape Pfizer's investment outlook and what to watch going forward. Analyst Price Targets don't always capture the full story. Head over to our Company...",
        "pubDate": "2025-11-14T18:08:48Z",
        "displayTime": "2025-11-14T18:08:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-moves-rewriting-story-pfizer-180848879.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-moves-rewriting-story-pfizer-180848879.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T17:18:03+00:00",
    "headline": "US Equity Indexes Mixed in Midday Trading",
    "summary": "US equity indexes were mixed in midday trading on Friday, with technology and energy leading the sec",
    "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-midday-171803753.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "27e9b051-2d2b-3104-bbae-b3fba390d12c",
      "content": {
        "id": "27e9b051-2d2b-3104-bbae-b3fba390d12c",
        "contentType": "STORY",
        "title": "US Equity Indexes Mixed in Midday Trading",
        "description": "",
        "summary": "US equity indexes were mixed in midday trading on Friday, with technology and energy leading the sec",
        "pubDate": "2025-11-14T17:18:03Z",
        "displayTime": "2025-11-14T17:18:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-midday-171803753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-midday-171803753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T18:37:47+00:00",
    "headline": "US Equity Indexes Mixed as Technology Rebound Helps Lift Nasdaq, S&P 500",
    "summary": "US equity indexes were mixed in midday trading on Friday, with technology and energy leading the sec",
    "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-technology-183747204.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "d14250fc-983c-39e7-b15e-55eff6b92dc9",
      "content": {
        "id": "d14250fc-983c-39e7-b15e-55eff6b92dc9",
        "contentType": "STORY",
        "title": "US Equity Indexes Mixed as Technology Rebound Helps Lift Nasdaq, S&P 500",
        "description": "",
        "summary": "US equity indexes were mixed in midday trading on Friday, with technology and energy leading the sec",
        "pubDate": "2025-11-14T18:37:47Z",
        "displayTime": "2025-11-14T18:37:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-technology-183747204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-technology-183747204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MU"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T17:38:00+00:00",
    "headline": "Bristol Myers Shares Sink on Yet Another Trial Failure",
    "summary": "Bristol said it had decided to stop one of its ongoing Phase 3 trials testing an experimental blood thinner called milvexian.",
    "url": "https://www.barrons.com/articles/bristol-myers-shares-drug-trial-c8641bf0?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "04d2b710-ac12-3a6c-ae32-81762c4fc115",
      "content": {
        "id": "04d2b710-ac12-3a6c-ae32-81762c4fc115",
        "contentType": "STORY",
        "title": "Bristol Myers Shares Sink on Yet Another Trial Failure",
        "description": "",
        "summary": "Bristol said it had decided to stop one of its ongoing Phase 3 trials testing an experimental blood thinner called milvexian.",
        "pubDate": "2025-11-14T17:38:00Z",
        "displayTime": "2025-11-14T17:38:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/04d2b710-ac12-3a6c-ae32-81762c4fc115/bristol-myers-shares-sink-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/9caa34829b5c8a4ebd0971ea4a13deae",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1CS7dvdLCP2dmOCMKxwyjA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/9caa34829b5c8a4ebd0971ea4a13deae.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h2AamgfWHKIU3WrgGG2iXQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/9caa34829b5c8a4ebd0971ea4a13deae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/bristol-myers-shares-drug-trial-c8641bf0?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T17:34:55+00:00",
    "headline": "Top Stock Movers Now: StubHub, DoorDash, Netflix, and More",
    "summary": "Major U.S. equities indexes were mixed Friday afternoon, following a sharp decline Thursday fueled by a selloff of tech stocks.",
    "url": "https://www.investopedia.com/top-stock-movers-now-stubhub-doordash-netflix-and-more-11849593",
    "source": "Investopedia",
    "provider": "yfinance",
    "raw": {
      "id": "0f2db09d-c38a-3416-bddd-ebee2ec914f7",
      "content": {
        "id": "0f2db09d-c38a-3416-bddd-ebee2ec914f7",
        "contentType": "STORY",
        "title": "Top Stock Movers Now: StubHub, DoorDash, Netflix, and More",
        "description": "",
        "summary": "Major U.S. equities indexes were mixed Friday afternoon, following a sharp decline Thursday fueled by a selloff of tech stocks.",
        "pubDate": "2025-11-14T17:34:55Z",
        "displayTime": "2025-11-14T17:34:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/investopedia_245/df485ee9570def9b1d463f234d371242",
          "originalWidth": 4000,
          "originalHeight": 2668,
          "caption": "Michael Nagle / Bloomberg / Getty Images StubHub shares tumbled Friday after the ticket reseller declined to offer guidance for the current quarter",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wE5STsO0pbYbr0bVgK4bSQ--~B/aD0yNjY4O3c9NDAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/df485ee9570def9b1d463f234d371242.cf.webp",
              "width": 4000,
              "height": 2668,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pdC1m4roG.SrKhQ1nXQuuA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/investopedia_245/df485ee9570def9b1d463f234d371242.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investopedia",
          "url": "https://www.investopedia.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investopedia.com/top-stock-movers-now-stubhub-doordash-netflix-and-more-11849593",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-movers-now-stubhub-173455324.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "STUB"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "DASH"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CDTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T21:00:55+00:00",
    "headline": "Sector Update: Health Care Stocks Ease Late Afternoon",
    "summary": "Health care stocks fell late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Hea",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-ease-210055578.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "de2a9c0e-4558-3eba-9d81-5acdef31bb75",
      "content": {
        "id": "de2a9c0e-4558-3eba-9d81-5acdef31bb75",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Ease Late Afternoon",
        "description": "",
        "summary": "Health care stocks fell late Friday afternoon, with the NYSE Health Care Index down 0.3% and the Hea",
        "pubDate": "2025-11-14T21:00:55Z",
        "displayTime": "2025-11-14T21:00:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-ease-210055578.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-ease-210055578.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T20:56:47+00:00",
    "headline": "US Equity Indexes Mixed Amid Technology Rebound",
    "summary": "US equity indexes were mixed ahead of Friday's close amid selective dip-buying in technology and inf",
    "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-amid-205647266.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c2b2e547-b6e0-3efb-896a-5cf44b398536",
      "content": {
        "id": "c2b2e547-b6e0-3efb-896a-5cf44b398536",
        "contentType": "STORY",
        "title": "US Equity Indexes Mixed Amid Technology Rebound",
        "description": "",
        "summary": "US equity indexes were mixed ahead of Friday's close amid selective dip-buying in technology and inf",
        "pubDate": "2025-11-14T20:56:47Z",
        "displayTime": "2025-11-14T20:56:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-amid-205647266.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-equity-indexes-mixed-amid-205647266.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]